News
- Author:
- Bruce Jancin
Publish date: April 9, 2015
News
- Author:
- Bruce Jancin
Publish date: March 30, 2015
Key clinical point: Nearly half of overweight or obese patients with atrial fibrillation who achieved at least a 10% sustained weight loss remaine...
News
- Author:
- Bruce Jancin
Publish date: March 30, 2015
Key clinical point: Adding up the total number of cardiovascular events avoided by a medication in IMPROVE-IT rather than just the first one &ndas...
News
- Author:
- Bruce Jancin
Publish date: March 29, 2015
Key clinical point: Women without obstructive coronary artery disease who experience angina in response to emotional stress benefit from mindfulne...
Article
- Author:
- Bruce Jancin
Publish date: March 29, 2015
News
- Author:
- Bruce Jancin
Publish date: March 26, 2015
Key clinical point: Prescribing escitalopram in patients with major depressive disorder and heart failure with reduced ejection fraction did not i...
News
- Author:
- Bruce Jancin
Publish date: March 26, 2015
Key clinical point: Pulmonary artery denervation for PAH showed promise in a small study.
Major finding: Six-minute walk distance improved by 3.9...
News
- Author:
- Bruce Jancin
Publish date: March 25, 2015
Key clinical point: Concomitant use of an ACE inhibitor and alogliptin by patients with type 2 diabetes and high cardiovascular risk isn’t a...
News
- Author:
- Bruce Jancin
Publish date: March 25, 2015
Key clinical point: Successful treatment of periodontal disease may reduce the risk of future cardiovascular disease.
News
- Author:
- Bruce Jancin
Publish date: March 25, 2015
Key clinical point: A novel agent that boosts mitochondrial energy did not prevent irreversible reperfusion injury in MI patients undergoing percu...
News
- Author:
- Bruce Jancin
Publish date: March 23, 2015
Key clinical point: Catheter ablation is hands down more effective than amiodarone for the treatment of persistent atrial fibrillation in patients...
News
- Author:
- Bruce Jancin
Publish date: March 23, 2015
News
- Author:
- Bruce Jancin
Publish date: March 18, 2015
Key clinical point: Baroreflex activation therapy is safe and improves multiple aspects of NYHA class III heart failure with reduced ejection frac...
News
- Author:
- Bruce Jancin
Publish date: March 15, 2015
Key clinical point: Evolocumab shows impressive LDL lowering and slashes cardiovascular events.
News
- Author:
- Bruce Jancin
Publish date: March 15, 2015
Key clinical point: Closer monitoring for development of cancer in MI survivors may be warranted.
